Mdxhealth SA Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
MDXH
Mdxhealth SASCHEDULE: Lytton Holds 9.6% Stake in MDxHealth SA
Laurence W. Lytton has reported a beneficial ownership of 9.6% in MDxHealth SA's ordinary shares.
NASDAQ
MDXH
Mdxhealth SAAWM Investment Company, Inc. has filed a Schedule 13G amendment, reporting zero beneficial ownership of MDxHealth SA common stock as of June 30, 2026.
NASDAQ
MDXH
Mdxhealth SAExact Sciences Corporation and its subsidiary, Genomic Health, Inc., have reported a 12.0% beneficial ownership stake in MDxHealth SA ordinary shares.
NASDAQ
MDXH
Mdxhealth SALaurence W. Lytton has filed an amended Schedule 13G, reporting beneficial ownership of 6.4% of MDxHealth SA's Ordinary Shares as of September 30, 2025.
NASDAQ
MDXH
Mdxhealth SASCHEDULE 13G/A: Bleichroeder Entities Disclose 15% Passive Stake in MDxHealth SA
Bleichroeder LP, Bleichroeder Holdings LLC, and Andrew Gundlach have jointly disclosed a 15% beneficial ownership stake in MDxHealth SA, holding 7,429,609 ordinary shares.
NASDAQ
MDXH
Mdxhealth SASCHEDULE 13G/A: Bleichroeder LP and Holdings Reaffirm 14.9% Stake in MDxHealth SA Through Latest SEC Filing
Bleichroeder LP and Bleichroeder Holdings LLC have filed an amendment to their Schedule 13G, confirming their beneficial ownership of 14.9% of MDxHealth SA's Ordinary Shares as of December 31, 2024.
NASDAQ
MDXH
Mdxhealth SASCHEDULE 13G/A: Laurence W. Lytton Discloses 8.4% Stake in MDxHealth SA via Amended Schedule 13G Filing
Laurence W. Lytton has filed an amended Schedule 13G, reporting beneficial ownership of 8.4% of MDxHealth SA's Ordinary Shares as of December 31, 2024.
NASDAQ
MDXH
Mdxhealth SASCHEDULE 13G/A: AWM Investment Company Discloses 10.3% Stake in MDxHealth SA
AWM Investment Company, Inc. has filed an amended Schedule 13G, revealing a 10.3% beneficial ownership stake in MDxHealth SA as of January 31, 2025.